首页 > 最新文献

Reproductive biomedicine online最新文献

英文 中文
Genetic alteration of mRNA editing enzyme APOBEC3B in the pathogenesis of ovarian endometriosis mRNA编辑酶APOBEC3B在卵巢子宫内膜异位症发病机制中的基因改变
IF 3.7 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-05-23 DOI: 10.1016/j.rbmo.2024.104111

Research question

What are the specific genetic alterations and associated network in endometriotic cells responsible for the disease pathogenesis?

Design

Case control experimental study involving 45 women with endometriosis who underwent laparoscopic surgery (case) and 45 normal samples from women undergoing total abdominal hysterectomy (control). The endometrial samples were subjected to whole exome sequencing (WES) of endometriotic tissue and copy number variation analysis. Validation of gene hits were obtained from WES using polymerase chain reaction techniques, immunological techniques, in-silico tools and transgenic cell line models.

Results

Germline heterozygous deletion of mRNA editing enzyme subunit APOBEC3B was identified in about 96% of endometriosis samples. The presence of germline deletion was confirmed with blood, endometrium and normal ovary samples obtained from the same patient. APOBEC3B deletions resulted in a hybrid protein that activates A1CF. APOBEC3B deletion can be a major cause of changes in the endometriotic microenvironment, and contributes to the pathogenesis and manifestation of the disease. The effect of APOBEC3B deletion was proved by in-vitro experiments in a cell line model, which displayed endometriosis-like characteristics. APOBEC3B germline deletion plays a major role in the pathogenesis of endometriosis, which is evident by the activation of A1CF, an increase in epithelial to mesenchymal transition, cellular proliferation, inflammation markers and a decrease in apoptosis markers.

Conclusion

The deleterious effects caused by APOBEC3B deletion in endometriosis were identified and confirmed. These results might provide a base for identifying the complete pathogenetic mechanism of endometriosis, thereby moving a step closer to better diagnosis and treatment options.

研究问题子宫内膜异位症细胞中导致疾病发病机制的特定基因改变和相关网络是什么?设计病例对照实验研究,涉及 45 名接受腹腔镜手术的子宫内膜异位症妇女(病例)和 45 名接受全腹子宫切除术的正常妇女样本(对照)。对子宫内膜样本进行了子宫内膜异位组织全外显子组测序(WES)和拷贝数变异分析。利用聚合酶链式反应技术、免疫学技术、硅内工具和转基因细胞系模型对 WES 中的基因进行了验证。结果在约 96% 的子宫内膜异位症样本中发现了 mRNA 编辑酶亚基 APOBEC3B 的种系杂合缺失。同一患者的血液、子宫内膜和正常卵巢样本均证实存在种系缺失。APOBEC3B 基因缺失产生的杂交蛋白可激活 A1CF。APOBEC3B 基因缺失可能是子宫内膜异位症微环境变化的主要原因,并有助于该疾病的发病机制和表现。APOBEC3B缺失的影响已通过细胞系模型的体外实验得到证实,该模型显示出子宫内膜异位症样特征。APOBEC3B种系缺失在子宫内膜异位症的发病机制中起着重要作用,这体现在A1CF的激活、上皮到间质转化的增加、细胞增殖、炎症标志物和凋亡标志物的减少等方面。这些结果可能为确定子宫内膜异位症的完整发病机制提供了依据,从而向更好的诊断和治疗方案迈进了一步。
{"title":"Genetic alteration of mRNA editing enzyme APOBEC3B in the pathogenesis of ovarian endometriosis","authors":"","doi":"10.1016/j.rbmo.2024.104111","DOIUrl":"10.1016/j.rbmo.2024.104111","url":null,"abstract":"<div><h3>Research question</h3><p>What are the specific genetic alterations and associated network in endometriotic cells responsible for the disease pathogenesis?</p></div><div><h3>Design</h3><p>Case control experimental study involving 45 women with endometriosis who underwent laparoscopic surgery (case) and 45 normal samples from women undergoing total abdominal hysterectomy (control). The endometrial samples were subjected to whole exome sequencing (WES) of endometriotic tissue and copy number variation analysis. Validation of gene hits were obtained from WES using polymerase chain reaction techniques, immunological techniques, in-silico tools and transgenic cell line models.</p></div><div><h3>Results</h3><p>Germline heterozygous deletion of mRNA editing enzyme subunit <em>APOBEC3B</em> was identified in about 96% of endometriosis samples. The presence of germline deletion was confirmed with blood, endometrium and normal ovary samples obtained from the same patient. <em>APOBEC3B</em> deletions resulted in a hybrid protein that activates A1CF. <em>APOBEC3B</em> deletion can be a major cause of changes in the endometriotic microenvironment, and contributes to the pathogenesis and manifestation of the disease. The effect of <em>APOBEC3B</em> deletion was proved by in-vitro experiments in a cell line model, which displayed endometriosis-like characteristics. <em>APOBEC3B</em> germline deletion plays a major role in the pathogenesis of endometriosis, which is evident by the activation of A1CF, an increase in epithelial to mesenchymal transition, cellular proliferation, inflammation markers and a decrease in apoptosis markers.</p></div><div><h3>Conclusion</h3><p>The deleterious effects caused by <em>APOBEC3B</em> deletion in endometriosis were identified and confirmed. These results might provide a base for identifying the complete pathogenetic mechanism of endometriosis, thereby moving a step closer to better diagnosis and treatment options.</p></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"49 5","pages":"Article 104111"},"PeriodicalIF":3.7,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141137185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the effect of platelet-rich plasma on vascularization and survival of follicles in xenotransplanted human ovarian tissue 探索 PRP 对移植到免疫缺陷小鼠体内的人类卵巢组织中卵泡血管化和存活的影响
IF 3.7 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-05-23 DOI: 10.1016/j.rbmo.2024.104274

Research question

Do platelet-rich plasma (PRP) products, specifically human platelet lysate (hPL) and umbilical cord plasma, enhance vascularization and follicular survival in human ovarian tissue transplanted to immunodeficient mice?

Design

Human ovarian tissue was transplanted to subcutaneous pockets in nude mice, followed by daily injections for 6 days of PRP or saline at the transplantation sites. After a grafting period of 3 and 6 days, vascularization was assessed using CD-31 quantification, and gene expression of angiogenic markers (VEGF/Vegf) together with apoptosis-related genes (BAX/BCL-2), oxidative stress markers (HMOX-1/Hmox-1) and pro-inflammatory markers (Il-1β/Il-6/Tnf-α) was quantitively analysed. Follicle density was analysed in the grafts after 4 weeks. Additionally, a pilot study was conducted exploring the suitability of ultrasound scanning for assessing survival and vascularization in ovarian tissue xenografted to mice.

Results

Although there was a significant increase in the CD-31 area from day 3 to day 6 post-grafting, there were no significant differences between the hPL and control groups. Gene expression analysis revealed significant down-regulation of VEGF from day 3 to day 6 for both the hPL and control groups, and significant up-regulation of BAX/BCL-2 in the hPL group compared with the controls. The follicle density showed no significant differences in the hPL group and UCP groups compared with the controls. Furthermore, ultrasound biomicroscopy provided valuable insights into graft morphology, necrotic areas and blood flow, suggesting its potential as a monitoring tool.

Conclusions

Despite the angiogenic properties of PRP, this study was unable to demonstrate a significant impact of hPL on vascularization or of hPL and UCP on follicular survival in xenotransplanted human ovarian tissue.

研究问题富血小板血浆(PRP)产品,特别是人血小板裂解液(hPL)和脐带血浆,是否能增强移植到免疫缺陷小鼠体内的人卵巢组织的血管化和卵泡存活率? 设计将人卵巢组织移植到裸鼠的皮下袋中,然后每天在移植部位注射 PRP 或生理盐水,持续 6 天。移植 3 天和 6 天后,使用 CD-31 定量评估血管生成情况,并定量分析血管生成标志物(VEGF/Vegf)、凋亡相关基因(BAX/BCL-2)、氧化应激标志物(HMOX-1/Hmox-1)和促炎标志物(Il-1β/Il-6/Tnf-α)的基因表达。4 周后对移植物的卵泡密度进行分析。此外,还进行了一项试验性研究,探索超声扫描是否适合用于评估异种移植到小鼠体内的卵巢组织的存活率和血管化情况。结果虽然移植后第 3 天到第 6 天 CD-31 面积显著增加,但 hPL 组和对照组之间没有显著差异。基因表达分析表明,与对照组相比,移植后第 3 天至第 6 天,hPL 组和对照组的血管内皮生长因子(VEGF)均显著下调,而 hPL 组的 BAX/BCL-2 则显著上调。与对照组相比,hPL 组和 UCP 组的卵泡密度无明显差异。结论尽管PRP具有血管生成特性,但本研究未能证明hPL对异种移植人体卵巢组织的血管生成或hPL和UCP对卵泡存活有显著影响。
{"title":"Exploring the effect of platelet-rich plasma on vascularization and survival of follicles in xenotransplanted human ovarian tissue","authors":"","doi":"10.1016/j.rbmo.2024.104274","DOIUrl":"10.1016/j.rbmo.2024.104274","url":null,"abstract":"<div><h3>Research question</h3><p>Do platelet-rich plasma (PRP) products, specifically human platelet lysate (hPL) and umbilical cord plasma, enhance vascularization and follicular survival in human ovarian tissue transplanted to immunodeficient mice?</p></div><div><h3>Design</h3><p>Human ovarian tissue was transplanted to subcutaneous pockets in nude mice, followed by daily injections for 6 days of PRP or saline at the transplantation sites. After a grafting period of 3 and 6 days, vascularization was assessed using CD-31 quantification, and gene expression of angiogenic markers (<em>VEGF/Vegf</em>) together with apoptosis-related genes (<em>BAX/BCL-2</em>), oxidative stress markers (<em>HMOX-1/Hmox-1</em>) and pro-inflammatory markers (<em>Il-1β/Il-6/Tnf-α</em>) was quantitively analysed. Follicle density was analysed in the grafts after 4 weeks. Additionally, a pilot study was conducted exploring the suitability of ultrasound scanning for assessing survival and vascularization in ovarian tissue xenografted to mice.</p></div><div><h3>Results</h3><p>Although there was a significant increase in the CD-31 area from day 3 to day 6 post-grafting, there were no significant differences between the hPL and control groups. Gene expression analysis revealed significant down-regulation of <em>VEGF</em> from day 3 to day 6 for both the hPL and control groups, and significant up-regulation of <em>BAX/BCL-2</em> in the hPL group compared with the controls. The follicle density showed no significant differences in the hPL group and UCP groups compared with the controls. Furthermore, ultrasound biomicroscopy provided valuable insights into graft morphology, necrotic areas and blood flow, suggesting its potential as a monitoring tool.</p></div><div><h3>Conclusions</h3><p>Despite the angiogenic properties of PRP, this study was unable to demonstrate a significant impact of hPL on vascularization or of hPL and UCP on follicular survival in xenotransplanted human ovarian tissue.</p></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"49 4","pages":"Article 104274"},"PeriodicalIF":3.7,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1472648324004632/pdfft?md5=33ba0503db5a0159a5730f2a84905507&pid=1-s2.0-S1472648324004632-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141142753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to ‘ART in Latin America: the Latin American Registry, 2020’ [Reproductive BioMedicine Online (2023) Volume 47, Issue 2] 103195 拉丁美洲的抗逆转录病毒疗法:2020 年拉丁美洲登记册》更正[生殖生物医学在线(2023 年)第 47 卷第 2 期] 103195
IF 4 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-05-22 DOI: 10.1016/j.rbmo.2024.104272
Fernando Zegers-Hochschild , Javier A. Crosby , Carolina Musri , Fanny Petermann-Rocha , Maria de Carmo de Souza , A. Gustavo Martinez , Ricardo Azambuja , Armando Roque , Gustavo Estofan , Mario Croker , Latin American Network of Assisted Reproduction
{"title":"Corrigendum to ‘ART in Latin America: the Latin American Registry, 2020’ [Reproductive BioMedicine Online (2023) Volume 47, Issue 2] 103195","authors":"Fernando Zegers-Hochschild ,&nbsp;Javier A. Crosby ,&nbsp;Carolina Musri ,&nbsp;Fanny Petermann-Rocha ,&nbsp;Maria de Carmo de Souza ,&nbsp;A. Gustavo Martinez ,&nbsp;Ricardo Azambuja ,&nbsp;Armando Roque ,&nbsp;Gustavo Estofan ,&nbsp;Mario Croker ,&nbsp;Latin American Network of Assisted Reproduction","doi":"10.1016/j.rbmo.2024.104272","DOIUrl":"10.1016/j.rbmo.2024.104272","url":null,"abstract":"","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"49 2","pages":"Article 104272"},"PeriodicalIF":4.0,"publicationDate":"2024-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1472648324004619/pdfft?md5=06181d093dde0c82829b53d92bab599d&pid=1-s2.0-S1472648324004619-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141144027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancements in three-dimensional bioprinting for reproductive medicine: a systematic review 用于生殖医学的三维生物打印技术进展:系统综述
IF 3.7 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-05-21 DOI: 10.1016/j.rbmo.2024.104273

Reproductive failure due to age, genetics and disease necessitates innovative solutions. While reproductive tissue transplantation has advanced, ongoing research seeks superior approaches. Biomaterials, bioengineering and additive manufacturing, such as three-dimensional (3D) bioprinting, are harnessed to restore reproductive function. 3D bioprinting uses materials, cells and growth factors to mimic natural tissues, proving popular for tissue engineering, notably in complex scaffold creation with cell distribution. The versatility which is brought to reproductive medicine by 3D bioprinting allows more accurate and on-site applicability to various problems that are encountered in the field. However, in the literature, there is a lack of studies encompassing the valuable applications of 3D bioprinting in reproductive medicine. This systematic review aims to improve understanding, and focuses on applications in several branches of reproductive medicine. Advancements span the restoration of ovarian function, endometrial regeneration, vaginal reconstruction, and male germ cell bioengineering. 3D bioprinting holds untapped potential in reproductive medicine.

由于年龄、遗传和疾病导致的生殖功能衰竭需要创新的解决方案。虽然生殖组织移植已经取得了进展,但目前的研究仍在寻求更优越的方法。生物材料、生物工程和增材制造(如三维(3D)生物打印)被用来恢复生殖功能。三维生物打印利用材料、细胞和生长因子来模拟天然组织,在组织工程方面很受欢迎,特别是在创建复杂的细胞分布支架方面。三维生物打印技术为生殖医学带来了多功能性,可以更准确、更现场地解决生殖医学领域遇到的各种问题。然而,文献中缺乏对三维生物打印在生殖医学中的宝贵应用的研究。这篇系统性综述旨在增进人们的了解,重点关注生殖医学多个分支的应用。研究进展涵盖卵巢功能恢复、子宫内膜再生、阴道重建和男性生殖细胞生物工程。三维生物打印在生殖医学领域的潜力尚待开发。
{"title":"Advancements in three-dimensional bioprinting for reproductive medicine: a systematic review","authors":"","doi":"10.1016/j.rbmo.2024.104273","DOIUrl":"10.1016/j.rbmo.2024.104273","url":null,"abstract":"<div><p>Reproductive failure due to age, genetics and disease necessitates innovative solutions. While reproductive tissue transplantation has advanced, ongoing research seeks superior approaches. Biomaterials, bioengineering and additive manufacturing, such as three-dimensional (3D) bioprinting, are harnessed to restore reproductive function. 3D bioprinting uses materials, cells and growth factors to mimic natural tissues, proving popular for tissue engineering, notably in complex scaffold creation with cell distribution. The versatility which is brought to reproductive medicine by 3D bioprinting allows more accurate and on-site applicability to various problems that are encountered in the field. However, in the literature, there is a lack of studies encompassing the valuable applications of 3D bioprinting in reproductive medicine. This systematic review aims to improve understanding, and focuses on applications in several branches of reproductive medicine. Advancements span the restoration of ovarian function, endometrial regeneration, vaginal reconstruction, and male germ cell bioengineering. 3D bioprinting holds untapped potential in reproductive medicine.</p></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"49 4","pages":"Article 104273"},"PeriodicalIF":3.7,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141143086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Culture medium and protein supplementation affect sensitivity of the mouse embryo assay in detecting Triton X-100 培养基和蛋白质补充对小鼠胚胎测定法检测 Triton X-100 灵敏度的影响
IF 3.7 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-05-18 DOI: 10.1016/j.rbmo.2024.104120

Research question

To what extent does the type and concentration of protein and the type of culture medium affect the sensitivity of the mouse embryo assay (MEA) to detect Triton X-100 (TX-100) in culture media?

Design

The effect of the concentration of bovine serum albumin (BSA) and human serum albumin (HSA) was assessed by supplementing media with 0.5 or 5 mg/ml. Potassium-supplemented simplex optimized medium (KSOM) and human tubal fluid (HTF) were used as complex and simple formulation media, respectively. Variables were combined, forming study groups where embryos were cultured in test media spiked with a sublethal TX-100 concentration. The conditions of greatest sensitivity were determined by statistical comparison of blastocyst formation rates and total cell counts between groups.

Results

Although all of the study groups showed equal capacity for sustaining proper embryo development, the reported sensitivity of the MEA differed between groups when subjected to TX-100. HTF conferred significantly greater sensitivity than KSOM regardless of the type and concentration of protein used, and medium supplementation with 5 mg/ml BSA rather than 0.5 mg/ml BSA resulted in significantly higher sensitivity regardless of the type of medium used. This increase in concentration also resulted in higher sensitivity when supplementing HTF with HSA. The BSA groups provided more sensitivity than their HSA counterparts, except for the KSOM + 0.5 mg/ml BSA group. Cell count analysis did not provide further significant conclusions.

Conclusions

For TX-100 detection within culture medium, the type and concentration of protein and the type of culture medium have a direct effect on MEA sensitivity. These results could help to standardize the MEA protocol, and increase its ability to detect sublethal concentrations of embryotoxic substances, especially TX-100, thus avoiding possible clinical harmful effects.

研究问题蛋白质的类型和浓度以及培养基的类型在多大程度上影响小鼠胚胎测定法(MEA)检测培养基中Triton X-100(TX-100)的灵敏度? 设计通过在培养基中添加0.5或5 mg/ml的牛血清白蛋白(BSA)和人血清白蛋白(HSA)来评估其浓度的影响。钾补充的单克隆优化培养基(KSOM)和人类输卵管液(HTF)分别用作复合培养基和简单配方培养基。将各种变量进行组合,形成研究组,在这些研究组中,胚胎在添加了亚致死浓度 TX-100 的测试培养基中进行培养。结果虽然所有研究组在维持胚胎正常发育方面都表现出同等能力,但各组对 TX-100 的敏感性却不尽相同。无论使用哪种类型和浓度的蛋白质,HTF 的灵敏度都明显高于 KSOM;无论使用哪种类型的培养基,在培养基中添加 5 mg/ml BSA 而不是 0.5 mg/ml BSA 的灵敏度都明显更高。在 HTF 中添加 HSA 时,浓度的增加也会导致更高的灵敏度。除 KSOM + 0.5 mg/ml BSA 组外,BSA 组的灵敏度均高于 HSA 组。结论对于在培养基中检测 TX-100,蛋白质的类型和浓度以及培养基的类型会直接影响 MEA 的灵敏度。这些结果有助于规范 MEA 方案,提高其检测亚致死浓度胚胎毒性物质(尤其是 TX-100)的能力,从而避免可能的临床危害。
{"title":"Culture medium and protein supplementation affect sensitivity of the mouse embryo assay in detecting Triton X-100","authors":"","doi":"10.1016/j.rbmo.2024.104120","DOIUrl":"10.1016/j.rbmo.2024.104120","url":null,"abstract":"<div><h3>Research question</h3><p>To what extent does the type and concentration of protein and the type of culture medium affect the sensitivity of the mouse embryo assay (MEA) to detect Triton X-100 (TX-100) in culture media?</p></div><div><h3>Design</h3><p>The effect of the concentration of bovine serum albumin (BSA) and human serum albumin (HSA) was assessed by supplementing media with 0.5 or 5 mg/ml. Potassium-supplemented simplex optimized medium (KSOM) and human tubal fluid (HTF) were used as complex and simple formulation media, respectively. Variables were combined, forming study groups where embryos were cultured in test media spiked with a sublethal TX-100 concentration. The conditions of greatest sensitivity were determined by statistical comparison of blastocyst formation rates and total cell counts between groups.</p></div><div><h3>Results</h3><p>Although all of the study groups showed equal capacity for sustaining proper embryo development, the reported sensitivity of the MEA differed between groups when subjected to TX-100. HTF conferred significantly greater sensitivity than KSOM regardless of the type and concentration of protein used, and medium supplementation with 5 mg/ml BSA rather than 0.5 mg/ml BSA resulted in significantly higher sensitivity regardless of the type of medium used. This increase in concentration also resulted in higher sensitivity when supplementing HTF with HSA. The BSA groups provided more sensitivity than their HSA counterparts, except for the KSOM + 0.5 mg/ml BSA group. Cell count analysis did not provide further significant conclusions.</p></div><div><h3>Conclusions</h3><p>For TX-100 detection within culture medium, the type and concentration of protein and the type of culture medium have a direct effect on MEA sensitivity. These results could help to standardize the MEA protocol, and increase its ability to detect sublethal concentrations of embryotoxic substances, especially TX-100, thus avoiding possible clinical harmful effects.</p></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"49 4","pages":"Article 104120"},"PeriodicalIF":3.7,"publicationDate":"2024-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141139403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The dark side of random-start ovarian stimulation: ovarian hyperstimulation syndrome due to inadvertent pregnancy 随机启动卵巢刺激的阴暗面:意外妊娠导致的 OHSS
IF 3.7 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-05-18 DOI: 10.1016/j.rbmo.2024.104121

Research question

Can inadvertent pregnancies go unnoticed when initiating random-start ovarian stimulation (RSOS) despite monitoring?

Design

Case series at a university-based tertiary care fertility clinic.

Results

Between June 2022 and December 2023, two cases of undetected early pregnancy at the onset of RSOS were identified, both leading to severe ovarian hyperstimulation syndrome (OHSS) with hospitalization.

Conclusion

RSOS protocols add flexibility in fertility clinics when there is no intention of a fresh embryo transfer, but may be associated with insidious risk of OHSS. The authors advocate for comprehensive consultation and serial monitoring of human chorionic gonadotrophin during ovarian stimulation, while cautioning against over-reliance on baseline hormone concentrations when initiating RSOS. If the benefits of RSOS seem limited, healthcare providers should consider delaying ovarian stimulation to avert health, but also medicolegal and financial, complications.

研究问题:在启动随机启动卵巢刺激(RSOS)时,尽管进行了监测,但是否会发生意外妊娠而未被发现?结果在 2022 年 6 月至 2023 年 12 月期间,发现了两例在 RSOS 开始时未检测到的早孕病例,均导致严重的卵巢过度刺激综合征(OHSS)并住院治疗。作者主张在卵巢刺激过程中进行全面咨询并对人绒毛膜促性腺激素进行连续监测,同时提醒在启动 RSOS 时不要过度依赖激素基线浓度。如果 RSOS 的益处似乎有限,医疗服务提供者应考虑推迟卵巢刺激,以避免健康、医疗法律和财务方面的并发症。
{"title":"The dark side of random-start ovarian stimulation: ovarian hyperstimulation syndrome due to inadvertent pregnancy","authors":"","doi":"10.1016/j.rbmo.2024.104121","DOIUrl":"10.1016/j.rbmo.2024.104121","url":null,"abstract":"<div><h3>Research question</h3><p>Can inadvertent pregnancies go unnoticed when initiating random-start ovarian stimulation (RSOS) despite monitoring?</p></div><div><h3>Design</h3><p>Case series at a university-based tertiary care fertility clinic.</p></div><div><h3>Results</h3><p>Between June 2022 and December 2023, two cases of undetected early pregnancy at the onset of RSOS were identified, both leading to severe ovarian hyperstimulation syndrome (OHSS) with hospitalization.</p></div><div><h3>Conclusion</h3><p>RSOS protocols add flexibility in fertility clinics when there is no intention of a fresh embryo transfer, but may be associated with insidious risk of OHSS. The authors advocate for comprehensive consultation and serial monitoring of human chorionic gonadotrophin during ovarian stimulation, while cautioning against over-reliance on baseline hormone concentrations when initiating RSOS. If the benefits of RSOS seem limited, healthcare providers should consider delaying ovarian stimulation to avert health, but also medicolegal and financial, complications.</p></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"49 4","pages":"Article 104121"},"PeriodicalIF":3.7,"publicationDate":"2024-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1472648324003109/pdfft?md5=191c199b80b5f7378e834c89d67af5d3&pid=1-s2.0-S1472648324003109-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141141421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Business case for psychosocial interventions in clinics: potential for decrease in treatment discontinuation and costs 诊所心理干预的商业案例:减少治疗中断和成本的潜力
IF 3.7 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-05-18 DOI: 10.1016/j.rbmo.2024.104113

Research question

From a value-based healthcare (VBHC) perspective, does an assessment of clinical outcomes and intervention costs indicate that providing cognitive behavioural therapy (CBT) or mindfulness to women seeking fertility treatment add value compared with no such intervention?

Design

Proof-of-concept business case based on a VBHC perspective that considers clinical outcomes and costs. Potential effects on psychological and fertility outcomes were based on existing research. Cost outcomes were estimated with a costing model for the Dutch fertility treatment setting.

Results

Thirty-two studies were identified; 13 were included. Women who received CBT had 12% lower anxiety, 40% lower depression and 6% higher fertility quality of life; difference in clinical pregnancy rates was six percentage points (CBT [30.2%]; control [24.2%]); difference in fertility discontinuation rates was 10 percentage points (CBT [5.5%]; control [15.2%]). Women who received training in mindfulness had 8% lower anxiety, 45% lower depression and 21% higher fertility quality of life; difference in mean clinical pregnancy rate was 19 percentage points (mindfulness [44.8%]; control [26.0%]). Potential total cost savings was about €1.2 million per year if CBT was provided and €11 million if mindfulness was provided. Corresponding return on investment for CBT was 30.7%, and for mindfulness 288%. Potential cost benefits are influenced by the assumed clinical pregnancy rates; such data related to mindfulness were limited to one study.

Conclusions

The provision of CBT or mindfulness to women seeking fertility treatment could add value. Higher quality primary studies are needed on the effect of mindfulness on clinical pregnancy rates.

研究问题从基于价值的医疗保健(VBHC)的角度来看,对临床结果和干预成本的评估是否表明,为寻求生育治疗的女性提供认知行为疗法(CBT)或正念疗法比不提供此类干预更有价值?对心理和生育结果的潜在影响以现有研究为基础。使用荷兰生育治疗环境下的成本计算模型对成本结果进行了估算。接受 CBT 治疗的女性焦虑症降低了 12%,抑郁症降低了 40%,生育生活质量提高了 6%;临床妊娠率相差 6 个百分点(CBT [30.2%];对照组 [24.2%]);生育中止率相差 10 个百分点(CBT [5.5%];对照组 [15.2%])。接受正念训练的妇女焦虑症降低了 8%,抑郁症降低了 45%,生育生活质量提高了 21%;平均临床妊娠率相差 19 个百分点(正念训练 [44.8%];对照组 [26.0%])。如果提供 CBT,每年可能节省的总成本约为 120 万欧元;如果提供正念,每年可能节省的总成本约为 1100 万欧元。CBT 的相应投资回报率为 30.7%,正念的投资回报率为 288%。潜在的成本效益受到假定临床妊娠率的影响;与正念有关的数据仅限于一项研究。关于正念对临床妊娠率的影响,需要进行更高质量的初步研究。
{"title":"Business case for psychosocial interventions in clinics: potential for decrease in treatment discontinuation and costs","authors":"","doi":"10.1016/j.rbmo.2024.104113","DOIUrl":"10.1016/j.rbmo.2024.104113","url":null,"abstract":"<div><h3>Research question</h3><p>From a value-based healthcare (VBHC) perspective, does an assessment of clinical outcomes and intervention costs indicate that providing cognitive behavioural therapy (CBT) or mindfulness to women seeking fertility treatment add value compared with no such intervention?</p></div><div><h3>Design</h3><p>Proof-of-concept business case based on a VBHC perspective that considers clinical outcomes and costs. Potential effects on psychological and fertility outcomes were based on existing research. Cost outcomes were estimated with a costing model for the Dutch fertility treatment setting.</p></div><div><h3>Results</h3><p>Thirty-two studies were identified; 13 were included. Women who received CBT had 12% lower anxiety, 40% lower depression and 6% higher fertility quality of life; difference in clinical pregnancy rates was six percentage points (CBT [30.2%]; control [24.2%]); difference in fertility discontinuation rates was 10 percentage points (CBT [5.5%]; control [15.2%]). Women who received training in mindfulness had 8% lower anxiety, 45% lower depression and 21% higher fertility quality of life; difference in mean clinical pregnancy rate was 19 percentage points (mindfulness [44.8%]; control [26.0%]). Potential total cost savings was about €1.2 million per year if CBT was provided and €11 million if mindfulness was provided. Corresponding return on investment for CBT was 30.7%, and for mindfulness 288%. Potential cost benefits are influenced by the assumed clinical pregnancy rates; such data related to mindfulness were limited to one study.</p></div><div><h3>Conclusions</h3><p>The provision of CBT or mindfulness to women seeking fertility treatment could add value. Higher quality primary studies are needed on the effect of mindfulness on clinical pregnancy rates.</p></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"49 3","pages":"Article 104113"},"PeriodicalIF":3.7,"publicationDate":"2024-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141130360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of breast cancer prognostic factors on ovarian reserve and response in fertility preservation 乳腺癌预后因素对卵巢储备和生育力保存中卵巢刺激反应的影响
IF 3.7 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-05-17 DOI: 10.1016/j.rbmo.2024.104109

Research question

Do breast cancer prognostic factors influence ovarian reserve and response to ovarian stimulation in the context of fertility preservation?

Design

Observational, bicentric retrospective study of 352 women with breast cancer who underwent ovarian stimulation using a random start gonadotrophin releasing hormone antagonist protocol and vitrified oocytes between November 2015 and August 2022. Serum anti-Müllerian hormone (AMH) levels and antral follicle count (AFC) were measured. The number of oocytes recovered, maturation rate and follicular output rate (FORT) were analysed according to patients’ characteristics and breast cancer prognostic factors.

Results

Median age was 34 years (31.1–37.1). Median AFC and serum AMH level were 17 (12–26) follicles and 2 (1.2–3.4) ng/ml, respectively. After ovarian stimulation, 10.5 (6.0–16.0) oocytes were recovered, with eight (4–13) being mature. Mean oocyte maturation rate was 79% (62–92). Antral follicle count (>12) significantly affected the risk of recovering fewer than eight mature oocytes (P < 0.0001, multivariate analysis). Follicular responsiveness to FSH, assessed by the follicular output rate (FORT index) and number of oocytes recovered, were 31% (21–50) and 10.5% (6.0–16.0), respectively. FORT index and ovarian stimulation outcomes were not influenced by breast cancer prognostic factors.

Conclusion

Breast cancer prognostic factors do not influence ovarian reserve markers or response to ovarian stimulation in fertility preservation. Therefore, tumour grade, triple-negative status, HER2 overexpression and high Ki67 should not alter the fertility-preservation strategy when considering ovarian stimulation for oocyte vitrification.

研究问题乳腺癌预后因素是否会影响卵巢储备功能以及在保留生育力的情况下对卵巢刺激的反应?设计对2015年11月至2022年8月期间使用随机起始促性腺激素释放激素拮抗剂方案和玻璃化卵母细胞进行卵巢刺激的352名乳腺癌女性进行观察性双中心回顾研究。测量了血清抗缪勒氏管激素(AMH)水平和前卵泡计数(AFC)。根据患者特征和乳腺癌预后因素,对回收的卵母细胞数量、成熟率和卵泡产出率(FORT)进行了分析。中位 AFC 和血清 AMH 水平分别为 17 (12-26) 个卵泡和 2 (1.2-3.4) 纳克/毫升。卵巢刺激后,回收了 10.5(6.0-16.0)个卵母细胞,其中 8(4-13)个成熟。平均卵母细胞成熟率为 79%(62-92)。前区卵泡数(>12)显著影响成熟卵母细胞少于 8 个的风险(P <0.0001,多变量分析)。以卵泡产出率(FORT指数)和回收卵母细胞数评估的卵泡对FSH的反应性分别为31%(21-50)和10.5%(6.0-16.0)。FORT指数和卵巢刺激结果不受乳腺癌预后因素的影响。因此,在考虑卵巢刺激卵母细胞玻璃化时,肿瘤分级、三阴状态、HER2过表达和高Ki67不应改变生育力保存策略。
{"title":"Effect of breast cancer prognostic factors on ovarian reserve and response in fertility preservation","authors":"","doi":"10.1016/j.rbmo.2024.104109","DOIUrl":"10.1016/j.rbmo.2024.104109","url":null,"abstract":"<div><h3>Research question</h3><p>Do breast cancer prognostic factors influence ovarian reserve and response to ovarian stimulation in the context of fertility preservation?</p></div><div><h3>Design</h3><p>Observational, bicentric retrospective study of 352 women with breast cancer who underwent ovarian stimulation using a random start gonadotrophin releasing hormone antagonist protocol and vitrified oocytes between November 2015 and August 2022. Serum anti-Müllerian hormone (AMH) levels and antral follicle count (AFC) were measured. The number of oocytes recovered, maturation rate and follicular output rate (FORT) were analysed according to patients’ characteristics and breast cancer prognostic factors.</p></div><div><h3>Results</h3><p>Median age was 34 years (31.1–37.1). Median AFC and serum AMH level were 17 (12–26) follicles and 2 (1.2–3.4) ng/ml, respectively. After ovarian stimulation, 10.5 (6.0–16.0) oocytes were recovered, with eight (4–13) being mature. Mean oocyte maturation rate was 79% (62–92). Antral follicle count (&gt;12) significantly affected the risk of recovering fewer than eight mature oocytes (<em>P</em> &lt; 0.0001, multivariate analysis). Follicular responsiveness to FSH, assessed by the follicular output rate (FORT index) and number of oocytes recovered, were 31% (21–50) and 10.5% (6.0–16.0), respectively. FORT index and ovarian stimulation outcomes were not influenced by breast cancer prognostic factors.</p></div><div><h3>Conclusion</h3><p>Breast cancer prognostic factors do not influence ovarian reserve markers or response to ovarian stimulation in fertility preservation. Therefore, tumour grade, triple-negative status, HER2 overexpression and high Ki67 should not alter the fertility-preservation strategy when considering ovarian stimulation for oocyte vitrification.</p></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"49 5","pages":"Article 104109"},"PeriodicalIF":3.7,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1472648324002980/pdfft?md5=57be71477de5d0a955ae8088a69204f3&pid=1-s2.0-S1472648324002980-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141026325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic accuracy of hysterosalpingo-foam sonography for assessment of fallopian tube patency in infertile women 子宫输卵管造影(HyFoSy)对不孕妇女输卵管通畅性评估的诊断准确性
IF 3.7 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-05-16 DOI: 10.1016/j.rbmo.2024.104112

Research question

What is the diagnostic accuracy of hysterosalpingo-foam sonography (HyFoSy), using two-dimensional ultrasound in tubal patency assessment in infertile women compared with laparoscopy with dye chromotubation?

Design

This prospective study was conducted at My Duc Hospital, Vietnam. Infertile women aged 18 years or older, who were scheduled for laparoscopy, were included. Visual Analogue Scale (VAS) score for perception of pain during HyFoSy was used. Laparoscopy was carried out on the same day. Clinicians undertaking laparoscopy were blinded to HyFoSy results. Sensitivity, specificity, negative and positive predictive value, and 95% confidence intervals were calculated. A sample size of 455 women (n = 910 fallopian tubes) was needed to demonstrate a fluctuation hypothesis, not exceeding 6%, for sensitivity and specificity (power 0.80, two-sided alpha 5%, loss to follow-up 5%).

Results

Between 2019 and 2022, 455 participants were recruited. Hysterosalpingo-foam sonography was unsuccessfully carried out in six participants. Two withdrew their consent. Data analysis was conducted on the remaining 447 participants (n = 868 fallopian tubes). The sensitivity and specificity of hysterosalpingo-foam sonography compared with laparoscopy were 0.75 (95% CI 0.71 to 0.79) and 0.70 (95% CI 0.65 to 0.74), respectively. Hysterosalpingo-foam sonography gave a positive predictive value of 0.76 (95% CI 0.73 to 0.80) and negative predictive value of 0.68 (95% CI 0.64 to 0.73). A total of 42.8% of women reported a VAS score of no pain. No adverse event was reported.

Conclusion

Compared with laparoscopy with dye chromotubation, two-dimensional HyFoSy is a well-tolerated, reliable technique for assessing tubal patency.

研究问题在不孕妇女的输卵管通畅性评估中,使用二维超声波进行子宫输卵管造影(HyFoSy)与使用染色管的腹腔镜检查相比,诊断准确性如何?研究对象包括计划接受腹腔镜检查的 18 岁或以上不孕妇女。采用视觉模拟量表(VAS)对 HyFoSy 过程中的疼痛感进行评分。腹腔镜检查在同一天进行。进行腹腔镜检查的临床医生对 HyFoSy 的结果是盲法。计算了敏感性、特异性、阴性和阳性预测值以及 95% 的置信区间。需要455名妇女(n = 910输卵管)的样本量才能证明灵敏度和特异性不超过6%的波动假设(功率0.80,双侧α5%,随访损失5%)。结果2019年至2022年间,共招募了455名参与者。有 6 名参与者未能成功进行子宫输卵管泡沫超声检查。两人撤回了同意书。对剩余的 447 名参与者(n = 868 输卵管)进行了数据分析。与腹腔镜检查相比,子宫输卵管造影的敏感性和特异性分别为 0.75(95% CI 0.71 至 0.79)和 0.70(95% CI 0.65 至 0.74)。子宫输卵管造影的阳性预测值为 0.76(95% CI 0.73 至 0.80),阴性预测值为 0.68(95% CI 0.64 至 0.73)。共有 42.8% 的妇女报告 VAS 评分为无痛。结论与腹腔镜染色输卵管造影相比,二维 HyFoSy 是一种耐受性良好、可靠的输卵管通畅性评估技术。
{"title":"Diagnostic accuracy of hysterosalpingo-foam sonography for assessment of fallopian tube patency in infertile women","authors":"","doi":"10.1016/j.rbmo.2024.104112","DOIUrl":"10.1016/j.rbmo.2024.104112","url":null,"abstract":"<div><h3>Research question</h3><p>What is the diagnostic accuracy of hysterosalpingo-foam sonography (HyFoSy), using two-dimensional ultrasound in tubal patency assessment in infertile women compared with laparoscopy with dye chromotubation?</p></div><div><h3>Design</h3><p>This prospective study was conducted at My Duc Hospital, Vietnam. Infertile women aged 18 years or older, who were scheduled for laparoscopy, were included. Visual Analogue Scale (VAS) score for perception of pain during HyFoSy was used. Laparoscopy was carried out on the same day. Clinicians undertaking laparoscopy were blinded to HyFoSy results. Sensitivity, specificity, negative and positive predictive value, and 95% confidence intervals were calculated. A sample size of 455 women (<em>n</em> = 910 fallopian tubes) was needed to demonstrate a fluctuation hypothesis, not exceeding 6%, for sensitivity and specificity (power 0.80, two-sided alpha 5%, loss to follow-up 5%).</p></div><div><h3>Results</h3><p>Between 2019 and 2022, 455 participants were recruited. Hysterosalpingo-foam sonography was unsuccessfully carried out in six participants. Two withdrew their consent. Data analysis was conducted on the remaining 447 participants (<em>n</em> = 868 fallopian tubes). The sensitivity and specificity of hysterosalpingo-foam sonography compared with laparoscopy were 0.75 (95% CI 0.71 to 0.79) and 0.70 (95% CI 0.65 to 0.74), respectively. Hysterosalpingo-foam sonography gave a positive predictive value of 0.76 (95% CI 0.73 to 0.80) and negative predictive value of 0.68 (95% CI 0.64 to 0.73). A total of 42.8% of women reported a VAS score of no pain. No adverse event was reported.</p></div><div><h3>Conclusion</h3><p>Compared with laparoscopy with dye chromotubation, two-dimensional HyFoSy is a well-tolerated, reliable technique for assessing tubal patency.</p></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"49 3","pages":"Article 104112"},"PeriodicalIF":3.7,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141023673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formation of the first plane of division relative to the pronuclear axis predicts embryonic ploidy 相对于原核轴的第一个分裂面的形成可预测胚胎倍性
IF 3.7 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-05-13 DOI: 10.1016/j.rbmo.2024.104110
Yamato Mizobe, Yukari Kuwatsuru, Yuko Kuroki, Yumiko Fukumoto, Mari Tokudome, Harue Moewaki, Yuji Orita, Tokiko Iwakawa, Kazuhiro Takeuchi

Research question

Is there a relationship between the pronuclear axis and the first cleavage plane formation in human pronuclear-stage embryos, and what are the effects on ploidy and clinical pregnancy rates?

Design

Transferred embryos were followed up until their prognoses. A total of 762 embryos formed two cells and reached the blastocyst stage after normal fertilization in a time-lapse incubator. Embryos were classified into three groups: group A: embryos in which the first plane of division was formed parallel to the axis of the pronucleus; group B: embryos in which cases of oblique formation were observed; and group C: embryos in which cases of perpendicular formation were observed.

Results

The euploidy rate was significantly higher in groups A and B than those in group C (P < 0.01), whereas the aneuploidy rate was significantly higher in group C (P < 0.01) than in groups A and B. No differences were found between the three groups in frequency of positive HCG-based pregnancy tests, frequency of clinical pregnancies, miscarriage rates or delivery rates.

Conclusions

The formation pattern of the first plane of division relative to the pronuclear axis was a predictor of embryonic ploidy, with a reduced rate of euploidy and a high probability of aneuploidy observed when the first plane of division was perpendicular to the pronuclear axis.

研究问题人代核期胚胎的代核轴与第一裂面形成之间是否存在关系,对倍性和临床妊娠率有何影响?共有 762 个胚胎在延时培养箱中正常受精后形成两个细胞并达到囊胚期。胚胎被分为三组:A 组:胚胎的第一个分裂面平行于前核的轴线形成;B 组:胚胎的第一个分裂面斜向形成;C 组:胚胎的第一个分裂面垂直于前核的轴线形成。结论第一个分裂平面相对于原核轴的形成模式是胚胎倍性的预测因子,当第一个分裂平面垂直于原核轴时,胚胎的倍性率降低,而非整倍体的概率较高。
{"title":"Formation of the first plane of division relative to the pronuclear axis predicts embryonic ploidy","authors":"Yamato Mizobe,&nbsp;Yukari Kuwatsuru,&nbsp;Yuko Kuroki,&nbsp;Yumiko Fukumoto,&nbsp;Mari Tokudome,&nbsp;Harue Moewaki,&nbsp;Yuji Orita,&nbsp;Tokiko Iwakawa,&nbsp;Kazuhiro Takeuchi","doi":"10.1016/j.rbmo.2024.104110","DOIUrl":"10.1016/j.rbmo.2024.104110","url":null,"abstract":"<div><h3>Research question</h3><p>Is there a relationship between the pronuclear axis and the first cleavage plane formation in human pronuclear-stage embryos, and what are the effects on ploidy and clinical pregnancy rates?</p></div><div><h3>Design</h3><p>Transferred embryos were followed up until their prognoses. A total of 762 embryos formed two cells and reached the blastocyst stage after normal fertilization in a time-lapse incubator. Embryos were classified into three groups: group A: embryos in which the first plane of division was formed parallel to the axis of the pronucleus; group B: embryos in which cases of oblique formation were observed; and group C: embryos in which cases of perpendicular formation were observed.</p></div><div><h3>Results</h3><p>The euploidy rate was significantly higher in groups A and B than those in group C (<em>P</em> &lt; 0.01), whereas the aneuploidy rate was significantly higher in group C (<em>P</em> &lt; 0.01) than in groups A and B. No differences were found between the three groups in frequency of positive HCG-based pregnancy tests, frequency of clinical pregnancies, miscarriage rates or delivery rates.</p></div><div><h3>Conclusions</h3><p>The formation pattern of the first plane of division relative to the pronuclear axis was a predictor of embryonic ploidy, with a reduced rate of euploidy and a high probability of aneuploidy observed when the first plane of division was perpendicular to the pronuclear axis.</p></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"49 3","pages":"Article 104110"},"PeriodicalIF":3.7,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141049891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Reproductive biomedicine online
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1